Terms: = Sarcomas AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9 AND Prognosis
11 results:
1. Multidisciplinary management of adolescents and young adults (AYA) sarcoma: A successful effort of an adult high-volume cancer center.
Bertuzzi AF; Grimaudo MS; Laffi A; Giordano L; Gennaro N; Cariboni U; Siracusano LV; Quagliuolo V; Colombo P; Federico D; Renne SL; Specchia C; Cananzi F; Marrari A; Navarria P; Daolio PA; Bastoni S; Santoro A
Cancer Med; 2023 Aug; 12(15):16254-16263. PubMed ID: 37366268
[TBL] [Abstract] [Full Text] [Related]
2. Genetic polymorphisms of ERCC-1 and ERCC-2 are not prognostic markers in osteosarcoma patients with chemotherapy: A meta-analysis in Chinese population.
Liu D; Liu X
Medicine (Baltimore); 2018 Dec; 97(49):e13358. PubMed ID: 30544402
[TBL] [Abstract] [Full Text] [Related]
3. Genetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma.
Wang MJ; Zhu Y; Guo XJ; Tian ZZ
Genet Mol Res; 2015 Sep; 14(3):11652-7. PubMed ID: 26436406
[TBL] [Abstract] [Full Text] [Related]
4. Letter regarding Li JS et al. entitled "ERCC polymorphisms and prognosis of patients with osteosarcoma".
Jian Y; Tian X; Li B; Zhou Z; Wu X
Tumour Biol; 2015 May; 36(5):3195-6. PubMed ID: 25824708
[TBL] [Abstract] [Full Text] [Related]
5. ERCC polymorphisms and prognosis of patients with osteosarcoma.
Li J; Liu S; Wang W; Zhang K; Liu Z; Zhang C; Chen S; Wu S
Tumour Biol; 2014 Oct; 35(10):10129-36. PubMed ID: 25023406
[TBL] [Abstract] [Full Text] [Related]
6. Common gene variants in RAD51, XRCC2 and xpd are not associated with clinical outcome in soft-tissue sarcoma patients.
Szkandera J; Absenger G; Liegl-Atzwanger B; Pichler M; Stotz M; Gerger S; Zacherl M; Renner W; Haijun M; Leithner A; Gerger A
Cancer Epidemiol; 2013 Dec; 37(6):1003-9. PubMed ID: 24189466
[TBL] [Abstract] [Full Text] [Related]
7. Glutathione S-transferase P1 and DNA polymorphisms influence response to chemotherapy and prognosis of bone tumors.
Yang LM; Li XH; Bao CF
Asian Pac J Cancer Prev; 2012; 13(11):5883-6. PubMed ID: 23317281
[TBL] [Abstract] [Full Text] [Related]
8. Association of four ERCC1 and ercc2 SNPs with survival of bone tumour patients.
Hao T; Feng W; Zhang J; Sun YJ; Wang G
Asian Pac J Cancer Prev; 2012; 13(8):3821-4. PubMed ID: 23098477
[TBL] [Abstract] [Full Text] [Related]
9. Nucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy.
Biason P; Hattinger CM; Innocenti F; Talamini R; Alberghini M; Scotlandi K; Zanusso C; Serra M; Toffoli G
Pharmacogenomics J; 2012 Dec; 12(6):476-83. PubMed ID: 21826087
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathologic study of 24 patients with primary cardiac sarcomas: a 10-year single institution experience.
Kim CH; Dancer JY; Coffey D; Zhai QJ; Reardon M; Ayala AG; Ro JY
Hum Pathol; 2008 Jun; 39(6):933-8. PubMed ID: 18538171
[TBL] [Abstract] [Full Text] [Related]
11. [Expressions of ercc2 and ERCC4 genes in osteosarcoma and peripheral blood lymphocytes and their clinical significance].
Li X; Guo W; Shen DH; Yang RL; Liu J; Zhao H
Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 39(5):467-71. PubMed ID: 17940561
[TBL] [Abstract] [Full Text] [Related]